Found: 91
Select item for more details and to access through your institution.
Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2010, v. 136, n. 7, p. 1059, doi. 10.1007/s00432-009-0752-8
- By:
- Publication type:
- Article
Adipocytokines and squamous cell carcinoma of the esophagus.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2010, v. 136, n. 2, p. 261, doi. 10.1007/s00432-009-0657-6
- By:
- Publication type:
- Article
Sequential chemotherapy with methotrexate and 5-fluorouracil for chemotherapy-naive advanced gastric cancer with disseminated intravascular coagulation at initial diagnosis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2010, v. 136, n. 2, p. 243, doi. 10.1007/s00432-009-0655-8
- By:
- Publication type:
- Article
Palliative radiation therapy for hemorrhage of unresectable gastric cancer: a single institute experience.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2009, v. 135, n. 8, p. 1117, doi. 10.1007/s00432-009-0553-0
- By:
- Publication type:
- Article
Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer.
- Published in:
- Journal of Gastroenterology, 2009, v. 44, n. 7, p. 685, doi. 10.1007/s00535-009-0063-5
- By:
- Publication type:
- Article
A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 2, p. 199, doi. 10.1093/jjco/hyaa190
- By:
- Publication type:
- Article
Co-operative groups in the development of chemotherapy for gastric cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 3, p. 210, doi. 10.1093/jjco/hyy176
- By:
- Publication type:
- Article
A Phase 1/1b tolerability study of rilotumumab alone or in combination with cisplatin and capecitabine in Japanese patients with gastric cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 11, p. 1002, doi. 10.1093/jjco/hyx114
- By:
- Publication type:
- Article
An orally administered oral pathobiont and commensal have comparable and innocuous systemic effects in germ‐free mice.
- Published in:
- Journal of Periodontal Research, 2018, v. 53, n. 6, p. 950, doi. 10.1111/jre.12593
- By:
- Publication type:
- Article
Poncet's Disease (Reactive Arthritis Associated with Tuberculosis).
- Published in:
- Internal Medicine, 2022, v. 61, n. 21, p. 3245, doi. 10.2169/internalmedicine.9241-21
- By:
- Publication type:
- Article
Perceptions regarding the concept and definition of patient-reported outcomes among healthcare stakeholders in Japan with relation to quality of life: a cross-sectional study.
- Published in:
- Health & Quality of Life Outcomes, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12955-023-02224-9
- By:
- Publication type:
- Article
Phase II study of cetuximab with irinotecan for KRAS wild-type colorectal cancer in Japanese patients.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 2, p. e132, doi. 10.1111/ajco.12405
- By:
- Publication type:
- Article
Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1021, doi. 10.1007/s10637-022-01287-7
- By:
- Publication type:
- Article
An exploration of trifluridine/tipiracil in combination with irinotecan in patients with pretreated advanced gastric cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 3, p. 614, doi. 10.1007/s10637-022-01223-9
- By:
- Publication type:
- Article
Phase I study of the anti-heparin-binding epidermal growth factor-like growth factor antibody U3-1565 with cetuximab in patients with cetuximab- or panitumumab-resistant metastatic colorectal cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 410, doi. 10.1007/s10637-019-00782-8
- By:
- Publication type:
- Article
Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with highly emetogenic risk antineoplastic agents: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 11, p. 1632, doi. 10.1007/s10147-024-02624-x
- By:
- Publication type:
- Article
Defining the clinical benefits of adding a neurokinin-1 receptor antagonist to control chemotherapy-induced nausea and vomiting in moderately emetogenic chemotherapy: a systematic review and meta-analysis of the clinical practice guidelines for antiemesis 2023 from the Japan society of clinical oncology
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 11, p. 1616, doi. 10.1007/s10147-024-02623-y
- By:
- Publication type:
- Article
Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 889, doi. 10.1007/s10147-024-02536-w
- By:
- Publication type:
- Article
2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 873, doi. 10.1007/s10147-024-02535-x
- By:
- Publication type:
- Article
Second-line chemotherapy using taxane in patients with advanced gastric cancer who presented with severe peritoneal metastasis: a multicenter retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 2, p. 355, doi. 10.1007/s10147-020-01802-x
- By:
- Publication type:
- Article
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 1, p. 1, doi. 10.1007/s10147-019-01485-z
- By:
- Publication type:
- Article
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 1, p. 1, doi. 10.1007/s10147-017-1101-6
- By:
- Publication type:
- Article
A retrospective analysis of periodontitis during bevacizumab treatment in metastatic colorectal cancer patients.
- Published in:
- International Journal of Clinical Oncology, 2013, v. 18, n. 6, p. 1020, doi. 10.1007/s10147-012-0478-5
- By:
- Publication type:
- Article
Phase II clinical trial of second-line FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer: AVASIRI trial.
- Published in:
- International Journal of Clinical Oncology, 2012, v. 17, n. 6, p. 604, doi. 10.1007/s10147-011-0331-2
- By:
- Publication type:
- Article
Systemic chemotherapy for peritoneal disseminated gastric cancer with inadequate oral intake: a retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2011, v. 16, n. 1, p. 57, doi. 10.1007/s10147-010-0135-9
- By:
- Publication type:
- Article
Targeting EGFR and RAS/RAF Signaling in the Treatment of Metastatic Colorectal Cancer: From Current Treatment Strategies to Future Perspectives.
- Published in:
- Drugs, 2019, v. 79, n. 6, p. 633, doi. 10.1007/s40265-019-01113-0
- By:
- Publication type:
- Article
Chronic Oral Infection with Porphyromonas gingivalis Accelerates Atheroma Formation by Shifting the Lipid Profile.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0020240
- By:
- Publication type:
- Article
Impact of Local Drug Delivery of Minocycline on the Subgingival Microbiota during Supportive Periodontal Therapy: A Randomized Controlled Pilot Study.
- Published in:
- Dentistry Journal, 2020, v. 8, n. 4, p. 123, doi. 10.3390/dj8040123
- By:
- Publication type:
- Article
Current Status and Issues of the Japan Oncofertility Registry.
- Published in:
- Journal of Adolescent & Young Adult Oncology, 2023, v. 12, n. 4, p. 584, doi. 10.1089/jayao.2022.0110
- By:
- Publication type:
- Article
Recent Developments of Systemic Chemotherapy for Gastric Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1100, doi. 10.3390/cancers12051100
- By:
- Publication type:
- Article
Disaster Relief Funding by Private Grants and POs: Actors Supporting "Paradise" After Disaster.
- Published in:
- Journal of Disaster Research, 2021, v. 16, n. 6, p. 953, doi. 10.20965/jdr.2021.p0953
- By:
- Publication type:
- Article
Effect of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients.
- Published in:
- Journal of Periodontal Research, 2005, v. 40, n. 1, p. 53, doi. 10.1111/j.1600-0765.2004.00772.x
- By:
- Publication type:
- Article
Immunohistological analysis of memory T lymphocytes and activated B lymphocytes in tissues with periodontal disease.
- Published in:
- Journal of Periodontal Research, 1993, v. 28, n. 5, p. 324, doi. 10.1111/j.1600-0765.1993.tb01076.x
- By:
- Publication type:
- Article
Effects of systemic sitafloxacin on periodontal infection control in elderly patients.
- Published in:
- Gerodontology, 2012, v. 29, n. 2, p. e1024, doi. 10.1111/j.1741-2358.2011.00605.x
- By:
- Publication type:
- Article
Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild‐type metastatic colorectal cancer: A phase II trial (HYBRID).
- Published in:
- Cancer Medicine, 2024, v. 13, n. 7, p. 1, doi. 10.1002/cam4.7107
- By:
- Publication type:
- Article
Clinical implications of using both fluoropyrimidine and paclitaxel in patients with severe peritoneal metastasis of gastric cancer: A post hoc study of JCOG1108/WJOG7312G.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 21, p. 7673, doi. 10.1002/cam4.4303
- By:
- Publication type:
- Article
IL-4- and IL-6-producing cells in human periodontal disease tissue.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Infusion site adverse events in breast cancer patients receiving highly emetic chemotherapy with prophylactic anti-emetic treatment with aprepitant and fosaprepitant: A retrospective comparison.
- Published in:
- Molecular & Clinical Oncology, 2016, v. 4, n. 4, p. 603, doi. 10.3892/mco.2016.769
- By:
- Publication type:
- Article
Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatin.
- Published in:
- Molecular & Clinical Oncology, 2015, v. 3, n. 5, p. 1029, doi. 10.3892/mco.2015.586
- By:
- Publication type:
- Article
Nursing Students' Use of Recovery Stories of People with Mental Illness in Their Experiences: A Qualitative Study.
- Published in:
- Nursing Reports, 2022, v. 12, n. 3, p. 610, doi. 10.3390/nursrep12030060
- By:
- Publication type:
- Article
Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil.
- Published in:
- International Journal of Cancer, 2008, v. 122, n. 9, p. 2148, doi. 10.1002/ijc.23381
- By:
- Publication type:
- Article
Phase II Study of Concurrent Chemoradiotherapy at the Dose of 50.4 Gy with Elective Nodal Irradiation for Stage II–III Esophageal Carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2013, v. 43, n. 6, p. 608, doi. 10.1093/jjco/hyt048
- By:
- Publication type:
- Article
Multicenter Feasibility Study of Combination Therapy with Fluorouracil, Leucovorin and Paclitaxel (FLTAX) for Peritoneal Disseminated Gastric Cancer with Massive Ascites or Inadequate Oral Intake.
- Published in:
- Japanese Journal of Clinical Oncology, 2012, v. 42, n. 9, p. 787, doi. 10.1093/jjco/hys111
- By:
- Publication type:
- Article
A Phase I Trial of 5-Fluorouracil with Cisplatin and Concurrent Standard-dose Radiotherapy in Japanese Patients with Stage II/III Esophageal Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2009, v. 39, n. 1, p. 37
- By:
- Publication type:
- Article
A Phase I Study of Bolus 5-Fluorouracil and Leucovorin Combined with Weekly Paclitaxel (FLTAX) as First-line Therapy for Advanced Gastric Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2008, v. 38, n. 8, p. 540, doi. 10.1093/jjco/hyn062
- By:
- Publication type:
- Article
Effect of Porphyromonas gingivalis infection on post-transcriptional regulation of the low-density lipoprotein receptor in mice.
- Published in:
- Lipids in Health & Disease, 2012, v. 11, n. 1, p. 121, doi. 10.1186/1476-511X-11-121
- By:
- Publication type:
- Article
Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase I study of cediranib in combination with cisplatin plus fluoropyrimidine (S-1 or capecitabine) in Japanese patients with previously untreated advanced gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 439, doi. 10.1007/s00280-011-1723-8
- By:
- Publication type:
- Article